Login
Home
Charts
Search
Watchlist
Products

Genomic Valley Biotech Ltd

GVBL·BSE
₹29.100.00%Mon, 21 Sept '26
Industry:Floriculture/Tissue Culture
Indices:

Genomic Valley Biotech Ltd

GVBL
BSE
₹29.10
0.00%
|Mon, 21 Sept '26
SOICxStockScans Reports
Industry
Floriculture/Tissue Culture
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹9Cr
Close
Close Price
₹29.10
Industry
Industry
Floriculture/Tissue Culture
PE
Price To Earnings
485.00
PS
Price To Sales
40.40
Revenue
Revenue
₹0Cr
Rev Gr TTM
Revenue Growth TTM
-71.79%
PAT Gr TTM
PAT Growth TTM
-96.00%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
250.0-94.0-100.0166.7200.0450.0-43.8-57.1-77.3-84.6-55.6
Expenses
ExpensesCr
000000000000
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
42.950.081.371.468.20.022.20.020.00.050.0
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
-66.7102.3-104.1333.3650.0700.0-100.0-84.6-100.0-93.887.5-50.0
NPM
NPM%
28.650.081.371.472.7-30.822.20.020.0-25.025.0
EPS
EPS₹
0.10.1-0.10.40.50.5-0.30.10.00.00.00.1
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
250.0-94.0-100.0166.7200.0450.0-43.8-57.1-77.3-84.6-55.6
Expenses
ExpensesCr
000000000000
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
42.950.081.371.468.20.022.20.020.00.050.0
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
-66.7102.3-104.1333.3650.0700.0-100.0-84.6-100.0-93.887.5-50.0
NPM
NPM%
28.650.081.371.472.7-30.822.20.020.0-25.025.0
EPS
EPS₹
0.10.1-0.10.40.50.5-0.30.10.00.00.00.1

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
001110030100
Growth
Revenue Growth%
259.0304.834.765.7-14.1-75.4-66.13,758.2-93.9411.3-68.0-71.8
Expenses
ExpensesCr
110100020000
Operating Profit
Operating ProfitCr
000010010000
OPM
OPM%
-421.6-23.416.942.065.0-66.3-535.532.38.952.114.813.6
Other Income
Other IncomeCr
00000010000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
00000-1010000
Tax
TaxCr
000000000000
PAT
PATCr
00000-1010000
Growth
PAT Growth%
-3,871.679.5149.7582.023.0-295.598.37,040.5-97.72,245.5-91.6-96.0
NPM
NPM%
-307.1-15.55.723.633.8-268.7-13.223.89.242.211.14.5
EPS
EPS₹
-1.1-0.20.10.80.9-1.80.02.10.11.20.10.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
001110030100
Growth
Revenue Growth%
259.0304.834.765.7-14.1-75.4-66.13,758.2-93.9411.3-68.0-71.8
Expenses
ExpensesCr
110100020000
Operating Profit
Operating ProfitCr
000010010000
OPM
OPM%
-421.6-23.416.942.065.0-66.3-535.532.38.952.114.813.6
Other Income
Other IncomeCr
00000010000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
00000-1010000
Tax
TaxCr
000000000000
PAT
PATCr
00000-1010000
Growth
PAT Growth%
-3,871.679.5149.7582.023.0-295.598.37,040.5-97.72,245.5-91.6-96.0
NPM
NPM%
-307.1-15.55.723.633.8-268.7-13.223.89.242.211.14.5
EPS
EPS₹
-1.1-0.20.10.80.9-1.80.02.10.11.20.10.1

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
33333333333
Reserves
ReservesCr
21122100011
Current Liabilities
Current LiabilitiesCr
11101101100
Non Current Liabilities
Non Current LiabilitiesCr
11122210000
Total Liabilities
Total LiabilitiesCr
66778844444
Current Assets
Current AssetsCr
00000013333
Non Current Assets
Non Current AssetsCr
66778732122
Total Assets
Total AssetsCr
66778844444
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
33333333333
Reserves
ReservesCr
21122100011
Current Liabilities
Current LiabilitiesCr
11101101100
Non Current Liabilities
Non Current LiabilitiesCr
11122210000
Total Liabilities
Total LiabilitiesCr
66778844444
Current Assets
Current AssetsCr
00000013333
Non Current Assets
Non Current AssetsCr
66778732122
Total Assets
Total AssetsCr
66778844444

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-101-101-2-1000
Investing Cash Flow
Investing Cash FlowCr
10-100-242000
Financing Cash Flow
Financing Cash FlowCr
000100-2-1000
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
-100-1003100
CFO To PAT
CFO To PAT%
205.3-508.22,561.3-446.1152.9-265.622,799.3-120.1-132.27.5-66.7
CFO To EBITDA
CFO To EBITDA%
149.5-337.7868.5-250.779.5-1,075.4563.6-88.6-136.26.1-50.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-101-101-2-1000
Investing Cash Flow
Investing Cash FlowCr
10-100-242000
Financing Cash Flow
Financing Cash FlowCr
000100-2-1000
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
-100-1003100
CFO To PAT
CFO To PAT%
205.3-508.22,561.3-446.1152.9-265.622,799.3-120.1-132.27.5-66.7
CFO To EBITDA
CFO To EBITDA%
149.5-337.7868.5-250.779.5-1,075.4563.6-88.6-136.26.1-50.0

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
111899
Price To Earnings
Price To Earnings
694.250.1285.0485.0
Price To Sales
Price To Sales
62.421.331.740.4
Price To Book
Price To Book
3.04.62.22.3
EV To EBITDA
EV To EBITDA
718.740.6213.0291.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.177.992.390.2105.745.99.941.5100.076.1
OPM
OPM%
-421.6-23.416.942.065.0-66.3-535.532.38.952.114.813.6
NPM
NPM%
-307.1-15.55.723.633.8-268.7-13.223.89.242.211.14.5
ROCE
ROCE%
-6.5-1.31.13.85.9-5.41.418.40.411.31.01.0
ROE
ROE%
-7.3-1.50.84.95.7-12.5-0.318.40.49.10.80.8
ROA
ROA%
-5.5-1.10.53.23.6-7.3-0.314.70.38.20.70.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
111899
Price To Earnings
Price To Earnings
694.250.1285.0485.0
Price To Sales
Price To Sales
62.421.331.740.4
Price To Book
Price To Book
3.04.62.22.3
EV To EBITDA
EV To EBITDA
718.740.6213.0291.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.177.992.390.2105.745.99.941.5100.076.1
OPM
OPM%
-421.6-23.416.942.065.0-66.3-535.532.38.952.114.813.6
NPM
NPM%
-307.1-15.55.723.633.8-268.7-13.223.89.242.211.14.5
ROCE
ROCE%
-6.5-1.31.13.85.9-5.41.418.40.411.31.01.0
ROE
ROE%
-7.3-1.50.84.95.7-12.5-0.318.40.49.10.80.8
ROA
ROA%
-5.5-1.10.53.23.6-7.3-0.314.70.38.20.70.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Genomic Valley Biotech Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/v3zdtihcyeqrgyrl28vp5n86.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/ci9flforfpaede209r3a9d70.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/7at9n6am3x1zcl8mene1xeug.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/jbit8qsnmzi9i6i8slnm4ou9.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/hrjba994efu9p75d61j1icrp.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/yf4t1bxdd6qsxrz335wu8cui.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/fpuriq3lkrx6i3u6rxe8erzn.pdf
  • Q3 FY2024 Quarterly Result (Dec 2023, PDF): https://www.stockscans.in/document/g7shnz5ikejiw5au9wmvqcwu.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/0ua3ipcfswy0w5seraqfyf9y.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/dp0ecik1o6phwautsx0squ7p.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/y0j8m8rcqooootkwxrsoxruq.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/4fyxlb7n9292vrk3biadfs02.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/la8lnshhewnjd0933ne0kfos.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/5qzhtz99am7twpln7v1w72pr.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies